Clinical trial
A REAL-WORLD STUDY ON THE EFFECTIVENESS OF NIRMATRELVIR-RITONAVIR IN REDUCING SEVERE OUTCOMES FROM COVID-19
NCT07261085 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A REAL-WORLD STUDY ON THE EFFECTIVENESS OF NIRMATRELVIR-RITONAVIR IN REDUCING SEVERE OUTCOMES FROM COVID-19
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 27, 2025
- Completion date
- February 26, 2026
- Enrollment
- 99,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.